These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37619596)

  • 1. Evaluation of the Association Between Sociodemographic Status and Breast Screening Volumes During the COVID-19 Pandemic in a Provincial, Population-Based Organized Breast Screening Program.
    Bentley H; Raveinthiranathan N; Mar C; Tang T; Regier DA; Chi K; Simkin J; Kellow Z; Yong-Hing CJ; Woods RR
    Can Assoc Radiol J; 2024 May; 75(2):253-260. PubMed ID: 37619596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disproportionate Sociodemographic Effects of Suspended Breast Cancer Screening During the COVID-19 Pandemic.
    Narvacan K; Patlas MN
    Can Assoc Radiol J; 2024 May; 75(2):218-219. PubMed ID: 38063155
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
    Chung A; Chen Q; Curry W; Felix T; Tuan WJ
    Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Breast Cancer Screening Adherence During the COVID-19 Pandemic in a Cohort at Increased Inherited Cancer Risk in the United States.
    Harris A; Bather JR; Kawamoto K; Fiol GD; Bradshaw RL; Kaiser-Jackson L; Monahan R; Kohlmann W; Liu F; Ginsburg O; Goodman MS; Kaphingst KA
    Cancer Control; 2024; 31():10732748241272727. PubMed ID: 39420801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Screening Test Volume in the National Breast and Cervical Cancer Early Detection Program during the COVID-19 Pandemic, 2020-2022.
    Bermudez Y; DeGroff A; Miller J; Kenney K; Lockhart J; Joseph D; Richardson L
    Int J Environ Res Public Health; 2024 Jun; 21(7):. PubMed ID: 39063394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors.
    Miller MM; Meneveau MO; Rochman CM; Schroen AT; Lattimore CM; Gaspard PA; Cubbage RS; Showalter SL
    Breast Cancer Res Treat; 2021 Aug; 189(1):237-246. PubMed ID: 34032985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sociodemographic Factors Associated with Mailed Fecal Immunochemical Testing Uptake During the COVID-19 Pandemic: Substance Use Linked to Reduced Screening Completion in Younger Adults.
    Malani K; Sunkara N; Selig T; Tanzer JR; Elfanagely Y; Min M; Promrat K
    J Gastrointest Cancer; 2024 Sep; 55(3):1453-1455. PubMed ID: 38691256
    [No Abstract]   [Full Text] [Related]  

  • 8. Hindsight is 2020: Understanding the Impact of the COVID-19 Pandemic on a Provincial Population-Based Breast Screening Program.
    Bentley H; Woods R; Mar C; Tang T; Raveinthiranathan N; Kellow Z; Yong-Hing CJ
    Can Assoc Radiol J; 2022 Aug; 73(3):589-591. PubMed ID: 34758655
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.
    Johnson KJ; O'Connell CP; Waken RJ; Barnes JM
    PLoS One; 2024; 19(5):e0303280. PubMed ID: 38768115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
    Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
    CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with deferral or non-performance of an organized breast cancer screening program during the COVID-19 pandemic in France.
    Stephanopoli JP; Bouazzi L; Guerbaz-Sommi M; Graesslin O; Hurtaud A; Ilardo S; Chrusciel J; Barbaret C; Bertrand C; Sanchez S
    Cancer Med; 2024 Aug; 13(16):e7444. PubMed ID: 39192606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Covid-19 on Breast Cancer Screening.
    Stevanato KP; Pelloso FC; Borghesan DHP; Ribeiro HF; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2024 Aug; 25(8):2703-2710. PubMed ID: 39205568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years + .
    Monsivais P; Amiri S; Robison J; Pflugeisen C; Kordas G; Amram O
    Breast Cancer; 2022 Jul; 29(4):740-746. PubMed ID: 35366175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiologist interpretive volume and breast cancer screening accuracy in a Canadian organized screening program.
    Théberge I; Chang SL; Vandal N; Daigle JM; Guertin MH; Pelletier E; Brisson J
    J Natl Cancer Inst; 2014 Mar; 106(3):djt461. PubMed ID: 24598715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database.
    Grimm LJ; Lee C; Rosenberg RD; Burleson J; Simanowith M; Fruscello T; Pelzl CE; Friedewald SM; Moy L; Zuley ML
    J Am Coll Radiol; 2022 Aug; 19(8):919-934. PubMed ID: 35690079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic.
    Crivellaro P; Tafur M; George R; Muradali D
    Eur Radiol; 2022 Jan; 32(1):613-620. PubMed ID: 34143286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Trends in Screening Mammography Volumes at a Tertiary Academic Institution During the COVID-19 Pandemic.
    Ambinder EB; Carson KA; Nguyen DL; Cha E; Peshtani A; Myers KS; Oluyemi ET
    J Am Coll Radiol; 2024 Jul; 21(7):1067-1071. PubMed ID: 38378103
    [No Abstract]   [Full Text] [Related]  

  • 20. Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland.
    O'Driscoll J; Mooney T; Kearney P; Williams Y; Lynch S; Connors A; Larke A; McNally S; O'Doherty A; Murphy L; Bennett KE; Fitzpatrick P; Mullooly M; Flanagan F
    J Med Screen; 2024 Sep; 31(3):182-190. PubMed ID: 38509806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.